127 related articles for article (PubMed ID: 17459473)
1. Transitory marrow aplasia during Imatinib therapy in a patient with chronic myeloid leukemia.
Cervetti G; Carulli G; Galimberti S; Azzarà A; Buda G; Orciuolo E; Pelosini M; Petrini M
Leuk Res; 2008 Jan; 32(1):194-5. PubMed ID: 17459473
[No Abstract] [Full Text] [Related]
2. Late-onset marrow aplasia due to imatinib in newly diagnosed chronic phase chronic myeloid leukaemia.
Chng WJ; Tan LH
Leuk Res; 2005 Jun; 29(6):719-20. PubMed ID: 15863215
[No Abstract] [Full Text] [Related]
3. Bone marrow aplasia--a rare complication of imatinib therapy in CML patients.
Srinivas U; Pillai LS; Kumar R; Pati HP; Saxena R
Am J Hematol; 2007 Apr; 82(4):314-6. PubMed ID: 17013815
[TBL] [Abstract][Full Text] [Related]
4. Late onset aplastic anemia during treatment of chronic myeloid leukemia with imatinib mesylate.
LeMarbre G; Schinstock C; Hoyer R; Krook J; Tefferi A
Leuk Res; 2007 Mar; 31(3):414-5. PubMed ID: 17010430
[No Abstract] [Full Text] [Related]
5. Reduction of immunoglobulin levels during imatinib therapy of chronic myeloid leukemia.
Cervetti G; Carulli G; Galimberti S; Azzarà A; Cannizzo E; Buda G; Orciuolo E; Petrini M
Leuk Res; 2008 Jan; 32(1):191-2. PubMed ID: 17397920
[No Abstract] [Full Text] [Related]
6. Sustained complete molecular remission after imatinib discontinuation due to severe aplastic anemia.
Hernández-Boluda JC; Collado M; Roda D; Amat P; Tormo M; Marugán I
Leuk Res; 2009 Apr; 33(4):589-92. PubMed ID: 18817972
[No Abstract] [Full Text] [Related]
7. Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.
Khan KA; Junaid A; Siddiqui NS; Mukhtar K; Siddiqui S
J Coll Physicians Surg Pak; 2008 Mar; 18(3):176-8. PubMed ID: 18460249
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia.
Galanopoulos A; Papadhimitriou SI; Kritikou-Griva E; Georgiakaki M; Anagnostopoulos NI
Ann Hematol; 2009 Mar; 88(3):281-2. PubMed ID: 18726593
[No Abstract] [Full Text] [Related]
9. Imatinib-induced aplastic anemia in a patient with chronic myeloid leukemia.
Mabed M; Elhefni AM; Damnhouri G
Leuk Lymphoma; 2012 Nov; 53(11):2310-1. PubMed ID: 22462614
[No Abstract] [Full Text] [Related]
10. Imatinib-lnduced agranulocytosis in a patient with chronic myelogenous leukemia in remission.
Khouri S; Kotliroff A; Lishner M; Amital H
Isr Med Assoc J; 2008 Apr; 10(4):320-1. PubMed ID: 18548994
[No Abstract] [Full Text] [Related]
11. Bone marrow necrosis related to imatinib mesylate therapy for cml bilineal blast crisis.
Campiotti L; Codari R; Appio L; Ultori C; Solbiati F; Maria Grandi A; Venco A
Leuk Res; 2007 Dec; 31(12):1768-70. PubMed ID: 17403537
[No Abstract] [Full Text] [Related]
12. Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib.
Woo SM; Huh CH; Park KC; Youn SW
J Dermatol; 2007 Oct; 34(10):724-6. PubMed ID: 17908148
[No Abstract] [Full Text] [Related]
13. Listeria monocytogenes meningitis following imatinib mesylate-induced monocytopenia in a patient with chronic myeloid leukemia.
Ferrand H; Tamburini J; Mouly S; Bouscary D; Bergmann JF
Clin Infect Dis; 2005 Dec; 41(11):1684-5. PubMed ID: 16267747
[No Abstract] [Full Text] [Related]
14. Pure red cell aplasia in a patient of chronic granulocyte leukemia associated with imatinib.
Meng HT; Li Y; Jin J; Qian WB; Yang CM
Ann Hematol; 2007 Mar; 86(3):231-2. PubMed ID: 17123082
[No Abstract] [Full Text] [Related]
15. Imatinib-induced erythrodermia in a patient with chronic myeloid leukemia.
Oztas P; Erbasi S; Lenk N; Polat M; Han O; Artuz F; Alli N
Acta Derm Venereol; 2006; 86(2):174-5. PubMed ID: 16648930
[No Abstract] [Full Text] [Related]
16. Alterations in creatine kinase, phosphate and lipid values in patients with chronic myeloid leukemia during treatment with imatinib.
Franceschino A; Tornaghi L; Benemacher V; Assouline S; Gambacorti-Passerini C
Haematologica; 2008 Feb; 93(2):317-8. PubMed ID: 18245661
[TBL] [Abstract][Full Text] [Related]
17. Prolonged imatinib-induced myelosuppression in chronic myeloid leukaemia with an unusually long survival.
Busuttil DP
Int J Lab Hematol; 2008 Feb; 30(1):68-70. PubMed ID: 18190471
[TBL] [Abstract][Full Text] [Related]
18. Irreversible sensorineural hearing loss due to Imatinib.
Attili VS; Bapsy PP; Anupama G; Lokanatha D
Leuk Res; 2008 Jun; 32(6):991-2. PubMed ID: 18221994
[TBL] [Abstract][Full Text] [Related]
19. Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy.
Ramasamy K; Hayden J; Lim Z; Mufti GJ; Ho AY
Br J Haematol; 2007 May; 137(4):374-5. PubMed ID: 17408403
[No Abstract] [Full Text] [Related]
20. Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection.
Thia TJ; Tan HH; Chuah TH; Chow WC; Lui HF
Singapore Med J; 2008 Mar; 49(3):e86-9. PubMed ID: 18362995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
